Context Therapeutics (NASDAQ:CNTX) Inc is beefing up its research and development team with the appointments of two new executives. Christopher Beck will take on the role of senior vice president of operations and Mark Fletcher will be the firm’s new vice president of research and development, according to a statement from the company. “Context is in a pivotal phase of growth and change as we near key inflection points with our pipeline, bolstered by our recent private placement and initial public offering,” CEO Martin Lehr told investors. “As part of Context’s leadership, Mr Beck and Dr Fletcher will help guide Context’s R&D operations, leveraging their proven knowledge, capabilities, and leadership skills to help Context achieve its product development objectives.”
Plurilock Security Inc. (TSX-V:PLUR) CEO Ian Paterson said the identity-centric cybersecurity solutions provider is well “positioned” for further growth in 2022. “Since 2016, Plurilock has rapidly grown, creating novel behavioral biometric technology and using it for our advanced cybersecurity solutions, to protect enterprises against the increasing cyber threat. As stated throughout the year, we believe that extending our distribution streams to scale the delivery of our technology solutions is imperative in driving sales and securing new clients,” Paterson said in a letter to shareholders. “With this in mind, we will continue to integrate with resellers and our existing distribution channels to capitalize on the growing demand from government, education, healthcare, and defense verticals. We believe this strategy continues to evolve as we continue to capture market share in the IAM market.”
Kontrol Technologies Corp (OTCQB:KNRLF, NEO:KNR). announced that it is shipping BioCloud units to distributors in Qatar and the Czech Republic as it continues to expand its technology footprint. “The growing movement to employ air quality monitoring and early detection systems in buildings positions BioCloud well for growing adoption,” said Kontrol CEO Paul Ghezzi in a statement. “Supported by an expanding global brand awareness and recognition of BioCloud as an innovative safe space solution, we expect to continue deployment of our technology to existing and new customers throughout the coming year.”
Zoglo's Incredible Food Corp. has entered into a consulting agreement with Boom Capital Markets Inc. for providing advisory services to the company. Pursuant to the terms and conditions of the consulting agreement, the company has granted 150,000 incentive stock options to Boom. Each stock option is exercisable for one common share in the capital of the company at an exercise price of $0.25 per share for a period of five years. One-third of the stock options vests immediately and one-third of the stock options will vest on each of the three-month and six-month anniversary of the grant date. The stock options are subject to the terms of the company's stock option plan, any necessary regulatory approvals and applicable securities law hold periods.
Esports Entertainment Group Inc announced today that its Board of Directors has declared monthly cash dividends for its 10.0% Series A Cumulative Redeemable Convertible Preferred Stock for January, February and March 2022. The firm has declared a dividend per share of $0.08.
Fobi AI (TSX-V:FOBI, OTCQB:FOBIF) Inc, which provides real-time data analytics through artificial intelligence, revealed that it has signed a $300,000 annual license with an auto-renewal with one of the world's leading insurance providers. “Fobi earns revenue from this deal through an annual license fee as well a license fee per Wallet pass issued, generating monthly recurring revenue,” said the company. Fobi’s Wallet pass platform will now enable the insurance provider to issue digital proof of insurance passes for both auto insurance and general insurance across five countries in Europe. The utilization of Wallet passes for digital proof of insurance by global insurance companies is very advanced, and with this deal, Fobi is now powering three of the top 10 global insurance providers with their Passcreator Wallet pass platform.
Vicinity Motor Corp. (TSX-V:VMC) said it has received an order from Olathe Fleet Solutions, a commercial truck dealership and fleet management company in Kansas, for over 150 VMC Optimal E1 electric chassis worth more than US$19 million. Vancouver-based Vicinity noted that Olathe, based in Olathe, Kansas is one of the nation's largest dealers in the commercial fleet industry - up-fitting and delivering over 20,000 trucks nationwide yearly. “This order is the culmination of effort and development which began many months ago with the Olathe team and key end-user involvement,” Vicinity founder and CEO William Trainer said in a statement. “As an authorized Ford ship-thru up-fitter, Olathe will be able to offer best-in-class EV solutions for customers across the Class 4 commercial vehicle spectrum.
Ultra Resources Inc (TSX-V:ULT) is poised to start drilling at its Laguna Verde lithium brine project in Argentina after signing a contract with drilling company Los Arcangeles SA. The Vancouver-based exploration company is planning to sink three drill holes between 200 and 400 metres, and an additional diamond drill hole that will reach a depth of 400 metres, according to a statement. Los Arcangeles SA is expected to start mobilizing its drill rigs in the second week of January.
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced a collaboration with McQuade Center for Strategic Research and Development LLC (MSRD) — a member of the global Otsuka family of pharmaceutical companies — to develop psychedelic medicine. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, the company said. “Exploring multiple paths is essential as we work to address the unique needs of individuals living with mental health conditions,” said Robert McQuade, president, McQuade Center for Strategic Research and Development. “We look forward to collaborating with Mindset on these assets and are hopeful that medical psychedelics could be approved to treat mental illness in the future.”
Ayurcann Holdings Corp, a leading Canadian cannabis extraction company, has announced the launch of its high potency THC branded “Fuego” vapes in Ontario. The Toronto-based company said it will launch the line of Fuego products through the Ontario Cannabis Store (OCS). Products will be made available through additional adult-use channels including authorized retailers across Ontario, it added. “We are thrilled to announce Fuego’s initial entrance into the largest Canadian market through the OCS, where we are optimistic about its market potential as an industry-leading value brand line,” CEO Igal Sudman said in a statement. “We have been successfully selling in NB, MB, SK (New Brunswick (NYSE:BC), Manitoba and Saskatchewan) and believe that the interest from consumers and retailers will help set the standard for vape products in Ontario.”
Altaley Mining Corporation (TSX-V:ATLY) told investors that construction of its Tahuehueto mine in Mexico was "very near" completion, while operational improvements at its producing Campo Morado asset continues to increase revenue and reduce costs. In a wide-ranging year-end update, the junior resource firm said it expects to enter a pre-production phase at half capacity at Tahuehueto during February 2022 when it will produce and sell gold-rich lead and zinc concentrate while declaring commercial production in the second half. Meanwhile, at Campo Morado, a five-year mine plan has been completed, which includes exploiting the El Largo, Fish, G9 and Southwest zones. Dewatering operations on the G9 and Southwest zones is nearly complete with the zone expected to be fully dewatered by the end of January this year. Copper concentrate production is earmarked to begin during the second quarter this year, which will add another revenue stream.
Magna Mining Inc (TSX-V:NICU) announced positive assay results from a further nine holes drilled at the Shakespeare mine during the 2021 drilling program. Highlights from the assay results include wide Gap Zone intersections which suggest that the West and East zones are connected both at near surface and at depth. The results continue to support the belief that the company can add significant open pit mineral resources to its Shakespeare deposit, Magna chief executive officer Jason Jessup said in a statement.
Bragg Gaming Group (TSX:BRAG, NASDAQ:BRAG) Inc said its wholly-owned subsidiary ORYX Gaming has introduced its content in the UK for the first time after going live with 888casino, one of the world’s leading online casino brands, just weeks after receiving its supplier licence in the country. The company said a selection of games from ORYX’s exclusive RGS (remote gaming server) offering has been added to 888casino in the UK, including games developed by ORYX’s in-house studio and titles from GAMOMAT. Egyptian Magic, the debut title from Bragg’s soon-to-launch proprietary game development studio, Atomic Slot Lab, will also be made available to local players. “The UK offers a substantial opportunity for Bragg to continue to grow its share in regulated global iGaming markets and we are thrilled to partner with 888, an already valued partner and one of the leading online betting and companies, for the launch of our content in the region,” Bragg chief commercial officer Chris Looney said in a statement.
American Manganese Inc. (TSX-V:AMY, OTCQB:AMYZF) said it is receiving additional advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support its lithium-ion battery recycling pilot project. The Surrey, British Columbia-based critical metals company said the support will be used to advance its research and development project, entitled ‘Demonstration of Continuous Recycling of Cathode Material from Lithium-ion Battery Production Scrap', which started in August 2021. The amendment expands existing assistance it is receiving from NRC IRAP, which it announced on August 13, 2021, the company added. "We have made great progress to date, and we are extremely pleased to receive this additional funding from NRC IRAP to support the completion of our project activities and objectives," president and CEO, Larry Reaugh, said in a statement.
Clean Air Metals Inc (TSX-V:AIR, OTCQB:CLRMF) announced new assay results from its 2021 drill campaign at the Escape and Current PGE copper-nickel deposits at the company's flagship high-grade Thunder Bay North project in Ontario. In a statement, the Thunder Bay, Ontario-based company said drilling operations will resume on January 6, 2022. The firm shared new assays from the Escape South high grade zone that included Hole ELR21-083A, which intersected 46 meters (m) grading 19.6 grams per tonne (g/t) palladium equivalency (PtEq), composed of 3.03 g/t platinum (Pt), 3.94 g/t palladium (Pd), 1.33% copper (Cu) and 0.51% nickel (Ni) from 399.0-445.0m downhole, including 31.0m grading 25.0 g/t PtEq composed of 3.90 g/t Pt, 5.10g/t Pd, 1.70% Cu and 0.63% Ni from 405.0-436.0m downhole.
KetamineOne Capital Ltd announced that Dr. Corey Hilmas has been appointed to its Medical Advisory Board (MAB) and will be assuming the role of interim chair. Additionally, Brigadier General (Ret.) Dr. Loree K. Sutton has also been appointed to the MAB. Dr. Hilmas currently also serves as the chief regulatory officer of the company’s wholly-owned subsidiary KGK Science Inc. KetamineOne said he is a respected scientist, medical doctor, and former federal food regulator in the US. After having completed his medical degree and a doctorate in toxicology, he worked as a principal investigator for many years and served on behalf of the US government at the Food and Drug Administration (FDA).
Western Magnesium Corp said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on November. 8, 2021, which will the issue of 1,375,499 shares at a purchase price of 68 Canadian cents (55 US cents) each together with 1,375,499 share purchase warrants with an exercise price of 93 Canadian cents (75 US cents) for a one-year period with 21 placees.
Kintara Therapeutics (NASDAQ:KTRA) Inc, a biopharma company focused on the development of new solid tumor cancer therapies, announced that its CEO Robert E. Hoffman will present at the HC Wainwright Bioconnect 2022 virtual conference from January 10-to-13, 2022. The presentation will be available on-demand beginning at 7:00 am ET on January 10, 2022, and will be available for 90 days. Investors can register to view the presentation here.
Numinus Wellness Inc, the mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results for the quarter ended November 30, 2021, after market close on Thursday, January 13, 2022. Interested parties are invited to participate in its Q1, 2022 results conference call and webcast, occurring on the same day, at 5.30 pm EST/ 2:30 pm PT. To listen to the live webcast, register here. To participate in the live conference call, please use the following dial-in information: 1 (833) 989-2968 (Toll-free North America); 1 (236) 714-4028 (International). A replay of the conference call can also be accessed after 8.30 pm ET/5.30pm PT on Thursday, January 13, 2022, at 1-800-585-8367 or 1-416-621-4642 (using passcode 2670376). The replay will be available until January 27, 2022.
TRACON Pharmaceuticals (NASDAQ:TCON), the clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics, has announced that Charles Theuer, the CEO, will present a corporate overview at the H.C. Wainwright BIOCONNECT Virtual Conference, being held January 10-13, 2022. The presentation will be available on-demand beginning at 7am EST on Monday, January 10, 2022, in the Investors section on the company’s website.
Adcore Inc (TSX:ADCO) (Adcore Inc (TSX:ADCO)) told investors that it signed 14 new clients during November and December 2021 for an aggregated estimated annual advertising budget of C$4.9 million. The Toronto-based company said its local teams will manage the digital marketing of the new clients, who are situated across four of its main regions, including North America, Europe, the Middle East and Africa (EMEA), Australia and New Zealand, and Greater China. "We are very pleased to see such strong ongoing momentum in our acquisition efforts,” the company’s founder and CEO Omri Brill said in a statement. “The fact that we were able not only to maintain but increase our acquisition levels during the November-December time period, traditionally weaker months for B2B acquisition due to the holidays, is an amazing achievement by itself.” Brill noted that almost half of the projected digital advertising budgets of the new clients originate from US-based businesses, a market Adcore previously announced to be one of its key growth drivers in 2022 and beyond.
BTU Metals Corp announced it has restarted its drilling program at its Red Lake, Ontario properties, which span around 230 square kilometres in the prolific gold district. Drilling at the Dixie Halo and Pakwash North projects will focus on exploring for gold, copper and silver across the properties, which border Great Bear Resources (TSX-V:GBR) Ltd’s esteemed Dixie project in the region. Great Bear is in the midst of a US$1.4 billion acquisition by mining major Kinross Gold.
Trust Stamp (OTCQX:IDAI, EURONEXT:AIID) Inc reports that it is advancing its innovative intellectual property portfolio. In a statement, the company said the US Patent and Trademark Office has allowed the applications for two US Non-Provisional Patent Application for issuance as patents and published an application for a third US Non-Provisional Patent Application. "As a result of our significant investment into research and development, Trust Stamp (OTCQX:IDAI, EURONEXT:AIID)'s robust privacy-first patent portfolio protects the unique benefits of our product offerings and enables us to deliver unparalleled security, utility, and privacy, at a fraction of the cost of traditional biometric solutions,” said CEO Gareth Genner in a statement.
Nevada-focused producer Fortitude Gold (OTCQB:FTCO) Corp has declared its monthly dividend of $0.04 per common share payable on January 31, 2022 to shareholders of record as of January 19, 2022.
Recruiter.com Group Inc announced that its CEO Evan Sohn will present and discuss the results of the company’s Recruiter Index for December 2021 on CNBC. Sohn will appear live on CNBC, Thursday, January 6, on "The Exchange," which airs from 1 p.m. to 2 p.m. ET. "I am thrilled to be once again joining "The Exchange" to share the latest recruiter sentiment results with the CNBC audience," said Sohn. "The demand for recruiters continues to rise as the 'great reevaluation' presses on. Employees know what they want and are no longer hesitant to look for a company that will provide them with just that. It truly is a candidates' market." The Recruiter Index, a survey of Recruiter.com's network of recruiters and talent acquisition professionals, has a successful track record of insights into the job market and hiring demand, as well as forecasting the Labor Department's jobs report by relying on the sentiment of recruiters, HR leaders, and hiring experts.
CytoDyn Inc announced positive results from the 350 mg weekly dose of its Phase 2 Nonalcoholic steatohepatitis (NASH) clinical trial. The Vancouver, British Columbia-based company said that the trial was conducted in two parts. Part one compared a 700 mg weekly dose and placebo in a double-blind randomized manner and Part two evaluated a 350 mg weekly dose as an open-label study compared to the same placebo blinded arm. “We are in the process of analyzing biomarker data including CCR5 haplotype information to better understand responder rates and mechanism of action,” said Christopher P. Recknor, CytoDyn’s senior executive vice president of clinical operations, in a statement. “Given 5% of the world’s population is estimated to have NASH with 20% progressing to cirrhosis, this signal gives hope for therapeutic intervention for this disease.”
Organic Garage (TSX-V:OG) (Organic Garage (TSX-V:OG)) Ltd CEO Matt Lurie has shared a year-end letter with shareholders, saying that the year 2021 was “an exciting year of accomplishment” for the company and its plant-based foods subsidiary, the Future of Cheese. “The company’s accomplishments in 2021 were truly transformational and have positioned Organic Garage (TSX-V:OG) (Organic Garage (TSX-V:OG)) for success in 2022,” said Lurie in a statement. “Our team at Organic Garage (TSX-V:OG) and the Future of Cheese are committed to the task at hand; delivering growth and value for all shareholders. Lurie noted that in 2022, the Future of Cheese is expected to launch an additional four to six stock-keeping units (SKUs) to provide a “compelling offer to retailers” as the company works towards national and international distribution. The Toronto-based company’s subsidiary is also looking to collaborate with a co-packer in 2022, allowing the Future of Cheese to focus on R&D, marketing, and promotion of the brand while leveraging the co-packer to rapidly scale the business, the CEO wrote
Broker Stifel GMP is upbeat on the prospects for Red Lake-focused Pure Gold Mining Inc following its recent announcement of management changes and an operational update. "Going back to basics with an emphasis on mine planning, scheduling, accountability and making definition drilling a priority is now a focus and what we think Pure Gold needs," analysts said in a note."While we are maintaining our HOLD rating and trimming our target price to C$1.30 (from $1.40), we are increasingly optimistic about the company's future, but are watching for proof of execution over the coming months," added the analysts.
Esports Entertainment Group Inc and its EEG Labs brand have announced a renewal of their partnership with Take-Two Interactive’s NBA 2K League, a professional esports league featuring the best NBA 2K players in the world. The Hoboken, New Jersey-based full-stack esports company said work is already in progress on the current season's NBA Draft Combine, an annual chance for the league's scouts and decision-makers to collect critical intel about players. Esports Entertainment has partnered with the NBA since the inception of the league and deploys advanced talent analytics and scouting technologies to determine the best for one of the world's top professional esports leagues.
LQwD FinTech Corp. (TSX-V:LQWD, OTCQB:LQWDF) CEO Shone Anstey said the Bitcoin Lightning Network-focused company has been quite active during the last six months as it expects further growth in 2022. In June 2021, it completed the acquisition of LQwD Financial Corp., creating the first publicly traded Lightning Network company that has a mission to develop institution-grade payment infrastructure and solutions. “The remarkable growth of the Lightning Network has validated LQwD's reason to be hyper-focused on Lightning and I look forward to continuing to expand our business on this rapidly growing global payment network," Anstey said in a statement.
Valeo Pharma Inc announced that its immune support product Hesperco is now available for sale at Loblaws stores across Canada. The unique flavonoid formulation is being sold at 300 stores under the Loblaws banner, including Dominion, Zehrs, Fortinio's, Your Independent Grocer and Superstore. Each Hesperco capsule contains 500mg of Valeo's unique hesperidin formulation and are available in bottles of 60 capsules. Hesperidin is a flavonoid with powerful antioxidant properties that help support the immune system.
Water Tower Research said it will host host Robert Anderson, CEO and president of Earthstone Energy for a fireside chat on Monday, January 10, 2022 at 2:30 pm EST. The discussion will focus on Earthstone’s recent success in the acquisition market, which has significantly expanded its Permian Basin asset base. Register at https://globalmeet.webcasts.com/starthere.jsp?ei=1516113&tp_key=6ebf5c23e3
Vuzix Corporation (NASDAQ:VUZI) (Vuzix Corporation (NASDAQ:VUZI)) has announced the unveiling of the Vuzix Shield Smart Glasses, which were recently named a multiple CES 2022 Innovation Awards honoree. The Rochester, New York-based company said the Vuzix Shield Smart Glasses, previously referred to as Vuzix Next Generation Smart Glasses (NGSG), represent the most powerful binocular optically see-through smart glasses built for enterprise customers to date in an untethered sleek eyeglass format. "The Vuzix Shield Smart Glasses were designed to be optically see-through and deliver the best-in-class in enterprise performance that our customers have grown accustomed to experiencing with our XR1-powered M400 and M4000," Vuzix president and CEO Paul Travers said in a statement. "This is our first product incorporating our latest uLED (microLED) display engines and advanced waveguide technologies with vastly improved optical performance and efficiency along with reduced sizing."
Esports Entertainment Group Inc announced today that its Board of Directors has declared monthly cash dividends for its 10.0% Series A Cumulative Redeemable Convertible Preferred Stock for January, February and March 2022. The firm has declared a dividend per share of $0.08.
Genprex Inc announced that it is participating in upcoming investor and healthcare conferences to be held in January 2022. Genprex’s President and Chief Executive Officer, Rodney Varner, and the Company’s Chief Medical Officer, Mark Berger, MD will lead the Company’s presentations, the company said. Details on Genprex’s participation in January conferences include:
Event: HC Wainwright BIOCONNECT 2022 Virtual Conference
Conference Dates: January 10-13, 2022
Presentation Time: Available on-demand beginning January 10 at 7 a.m. EST
Presenters: Rodney Varner, President and Chief Executive Officer and Mark Berger, MD, Chief Medical Officer
Conference Registration: https://bit.ly/3lMBq6G
Webcast Link:https://bit.ly/3q5EewX
Event: Biotech Showcase 2022
Conference Dates: January 10-13, 2022
Presentation Time: Available on-demand beginning January 10
Presenter: Rodney Varner, President and Chief Executive Officer
Conference Registration: https://bit.ly/3y80EB5
Event: Precision: Lung Cancer World R&D Virtual Summit
Conference Dates: January 25-26
Presentation Date: Tuesday,January 25
Presenters: Mark Berger, MD, Chief Medical Officer
Conference Registration: https://bit.ly/3pxW1wg
Event: CEO Roadshow
Presentation Date: Wednesday,January 26
Presentation Time: 11 a.m. EST
Presenters: Rodney Varner, President and Chief Executive Officer
Location: Virtual Webinar
Conference Registration: https://bit.ly/3IxMrSY